CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 87,269 shares at an average $25.96 ($2,265,339)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 88,395 shares at an average $26.56 ($2,347,335)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 479 shares (to pay taxes)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 18,259 shares at $20.29 ($370,475)
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
Page 11 of 39 · 778 filings